SCHEMBL4997219

SCHEMBL4997219

N[C@@H](CC(=O)O)C(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 2/20 0.69
DNPH1 O43598 9/20 0.66
P2RY1 P47900 4/20 0.64
TAS1R3 Q7RTX0 2/20 0.64
TAS1R1 Q7RTX1 2/20 0.64
P2RY2 P41231 2/20 0.64
PRKAB2 O43741 1/20 0.64
TRPM2 O94759 1/20 0.64
LDHA P00338 1/20 0.64
ADRB2 P07550 1/20 0.64
FBP1 P09467 1/20 0.64
SRC P12931 1/20 0.64
ADORA1 P30542 1/20 0.64
PRKAG1 P54619 1/20 0.64
PRKAA2 P54646 1/20 0.64
PDE4D Q08499 1/20 0.64
KCNH2 Q12809 1/20 0.64
PRKAA1 Q13131 1/20 0.64
PDE3A Q14432 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1933421 0.93 P2RY12 (0.67) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL5545796 0.92 P2RY12 (0.69) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL2990779 0.91 P2RY12 (0.66) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL3193571 0.91 P2RY12 (0.68) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL8916648 0.89 P2RY12 (0.70) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL4125974 0.89 P2RY12 (0.72) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL3898255 0.89 P2RY12 (0.65) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL8328071 0.88 P2RY12 (0.64) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL2990348 0.88 P2RY12 (0.68) P2RY12DNPH1P2RY1TAS1R3TAS1R1
SCHEMBL2988353 0.88 P2RY12 (0.68) P2RY12DNPH1P2RY1TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681504-B1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ICAGEN INC (US) 2023-08-23 EP disclosed
US-11573224-B2 Methods of detection using X-ray fluorescence ICAGEN, LLC (US) 2023-02-07 US disclosed
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
US-10877035-B2 Advanced drug development and manufacturing ICAGEN, LLC (US) 2020-12-29 US disclosed
US-20200278346-A1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ADJACENT ACQUISITION CO., LLC 2020-09-03 US disclosed
EP-3681504-A1 METHODS OF DETECTION USING X-RAY FLUORESCENCE Icagen, Inc. (US) 2020-07-22 EP disclosed
WO-2019055754-A1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ICAGEN, INC. (US) 2019-03-21 WO disclosed
WO-2018204764-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION (US) 2018-11-08 WO disclosed
WO-2016210373-A2 RECOMBINANT BACTERIA ENGINEERED FOR BIOSAFETY, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF SYNLOGIC, INC. (US) 2016-12-29 WO disclosed
US-20150309021-A1 Advanced Drug Development and Manufacturing LOS ALAMOS NATIONAL SECURITY, LLC 2015-10-29 US disclosed
EP-2511844-B1 X-ray microscope XRPRO SCIENCES INC (US) 2015-08-12 EP disclosed
EP-2511844-A2 Advanced drug development and manufacturing Los Alamos National Security, LLC (US) 2012-10-17 EP disclosed
EP-2084519-B1 X-RAY FLUORESCENCE ANALYSIS METHOD LOS ALAMOS NAT SECURITY LLC (US) 2012-08-01 EP disclosed
US-20080220441-A1 Advanced drug development and manufacturing THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-09-11 US disclosed
US-20050181464-A1 Novel purified polypeptides from bacteria AFFINIUM PHARMACEUTICALS, INC. (CA) 2005-08-18 US disclosed